全文获取类型
收费全文 | 2549篇 |
免费 | 143篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 120篇 |
妇产科学 | 37篇 |
基础医学 | 245篇 |
口腔科学 | 157篇 |
临床医学 | 210篇 |
内科学 | 511篇 |
皮肤病学 | 19篇 |
神经病学 | 369篇 |
特种医学 | 218篇 |
外科学 | 314篇 |
综合类 | 16篇 |
一般理论 | 1篇 |
预防医学 | 107篇 |
眼科学 | 21篇 |
药学 | 203篇 |
中国医学 | 1篇 |
肿瘤学 | 189篇 |
出版年
2023年 | 11篇 |
2022年 | 30篇 |
2021年 | 39篇 |
2020年 | 32篇 |
2019年 | 36篇 |
2018年 | 43篇 |
2017年 | 47篇 |
2016年 | 48篇 |
2015年 | 63篇 |
2014年 | 63篇 |
2013年 | 98篇 |
2012年 | 105篇 |
2011年 | 120篇 |
2010年 | 116篇 |
2009年 | 100篇 |
2008年 | 114篇 |
2007年 | 103篇 |
2006年 | 109篇 |
2005年 | 99篇 |
2004年 | 75篇 |
2003年 | 79篇 |
2002年 | 80篇 |
2001年 | 84篇 |
2000年 | 69篇 |
1999年 | 60篇 |
1998年 | 65篇 |
1997年 | 66篇 |
1996年 | 53篇 |
1995年 | 57篇 |
1994年 | 55篇 |
1993年 | 34篇 |
1992年 | 41篇 |
1991年 | 61篇 |
1990年 | 44篇 |
1989年 | 57篇 |
1988年 | 50篇 |
1987年 | 47篇 |
1986年 | 45篇 |
1985年 | 35篇 |
1984年 | 21篇 |
1983年 | 18篇 |
1982年 | 14篇 |
1981年 | 12篇 |
1980年 | 19篇 |
1979年 | 24篇 |
1978年 | 21篇 |
1977年 | 17篇 |
1976年 | 17篇 |
1974年 | 7篇 |
1966年 | 10篇 |
排序方式: 共有2751条查询结果,搜索用时 0 毫秒
81.
82.
Antonio Barone DDS PhD MSc Massimiliano Ricci DDS PhD student Ugo Covani MD DDS Ulf Nannmark DDS PhD Iman Azarmehr DDS Josè Luis Calvo‐Guirado DDS 《Clinical implant dentistry and related research》2012,14(3):373-379
Background: Insufficient alveolar bone height often prevents the placement of standard dental implants in the posterior part of edentulous maxilla. In order to increase adequately the vertical dimension of the reabsorbed alveolar process, a sinus lift procedure is often necessary. The aim of this study was to evaluate histologic results of a prehydrated corticocancellous porcine bone used in maxillary sinus augmentation. Methods: Patients (age 18–70 years) with a residual bone height requiring a maxillary sinus augmentation procedure to place dental implants were eligible for this study. All patients were treated with the same surgical technique consisting of sinus floor augmentation via a lateral approach. The space obtained by elevation of the mucosa wall was grafted with prehydrated and collagenated corticocancellous porcine bone. Biopsies were harvested 6 months after the augmentation procedures. Results: Twenty‐four patients were enrolled. The mean percentage of new formed bone was 43.9 ± 18.6% (range 7.5–100%), whereas the mean percentage of residual graft material was 14.2 ± 13.6% (range 0–41.9%). The new bone/residual graft material ratio in the maxillary sinuses was 3.1. The mean soft tissues percentage was 41.8 ± 22.7% (range 0–92.5%). Conclusion: The present study suggested that porcine bone showed excellent osteoconductive properties and could be used successfully for sinus augmentation. Moreover, the porcine bone showed a high percentage of reabsorption after 6 months; this might be because of the presence of collagen and the porosity of the graft material. 相似文献
83.
Finney BA Schweighoffer E Navarro-Núñez L Bénézech C Barone F Hughes CE Langan SA Lowe KL Pollitt AY Mourao-Sa D Sheardown S Nash GB Smithers N Reis e Sousa C Tybulewicz VL Watson SP 《Blood》2012,119(7):1747-1756
The C-type lectin receptor CLEC-2 signals through a pathway that is critically dependent on the tyrosine kinase Syk. We show that homozygous loss of either protein results in defects in brain vascular and lymphatic development, lung inflation, and perinatal lethality. Furthermore, we find that conditional deletion of Syk in the hematopoietic lineage, or conditional deletion of CLEC-2 or Syk in the megakaryocyte/platelet lineage, also causes defects in brain vascular and lymphatic development, although the mice are viable. In contrast, conditional deletion of Syk in other hematopoietic lineages had no effect on viability or brain vasculature and lymphatic development. We show that platelets, but not platelet releasate, modulate the migration and intercellular adhesion of lymphatic endothelial cells through a pathway that depends on CLEC-2 and Syk. These studies found that megakaryocyte/platelet expression of CLEC-2 and Syk is required for normal brain vasculature and lymphatic development and that platelet CLEC-2 and Syk directly modulate lymphatic endothelial cell behavior in vitro. 相似文献
84.
A. H. V. Schapira P. Barone R. A. Hauser Y. Mizuno O. Rascol M. Busse C. Debieuvre M. Fraessdorf W. Poewe for the Pramipexole ER Studies Group 《European journal of neurology》2013,20(1):50-56
Background and purpose: In chronic diseases including Parkinson’s disease (PD), complex pharmacotherapy dosing schedules are reported to reduce adherence, perhaps leading to less‐effective symptom control and, in PD, more erratic stimulation of dopamine receptors. However, blinded clinical‐trial designs preclude direct comparisons of adherence to various schedules. Methods: In two double‐blind (DB) studies of early PD and one of advanced PD, subjects received three‐times‐daily (t.i.d.) pramipexole or placebo. In open‐label (OL) extensions, subjects took extended‐release, once‐daily (q.d.) pramipexole. At 24 or 32 OL weeks, q.d. versus t.i.d. dosing preference was surveyed by questionnaire. Results: Of 590 DB‐trial completers with early PD, 511 entered the OL extension. Of 374 survey respondents, 94.4% preferred q.d. dosing (72.2% of them found it ‘very much more convenient’ and 27.8%‘more convenient’), 2.7% preferred t.i.d., and 2.9% chose ‘no difference’. Of 465 DB‐trial completers with advanced PD, 391 entered its OL extension. Of 334 survey respondents, 88.9% preferred q.d. dosing (59.9% of them found it ‘very much more convenient’ and 40.1%‘more convenient’), 5.7% preferred t.i.d., and 5.4% chose ‘no difference’. Results excluding DB‐placebo recipients were highly similar. Conclusions: In this first direct comparison of patient preference for q.d. versus t.i.d. dopamine‐agonist dosing, patients with early or advanced PD had a strong preference for q.d. rather than t.i.d. pramipexole. The high proportion of advanced‐PD patients declaring this preference indicates that it does not depend on whether a patient is taking concomitant PD medications dosed more frequently than q.d. 相似文献
85.
86.
87.
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients
Roberto Erro Gabriella Santangelo Marina Picillo Carmine Vitale Marianna Amboni Katia Longo Flavio Giordano Marcello Moccia Paolo Barone Maria Teresa Pellecchia 《Parkinsonism & related disorders》2013,19(2):256-259
BackgroundA relation between the side of motor onset and cognitive impairment in early PD has been reported, suggesting that the asymmetric degeneration affecting subcortical regions may play a pivotal role in lateralized cognitive function. However, evidences are controversial and all previous studies were performed on treated patients, though it is known that dopaminergic therapy can affect cognition in PD.MethodsSixty-nine early untreated PD patients underwent an extensive neuropsychological battery exploring memory, visuospatial and attention/executive functions. Patients were divided with respect of the side of onset (right vs. left) and further grouped according to motor phenotype (tremor vs. rigidity-bradykinesia). Multivariate analysis of variance has been carried out to compare clinical and neuropsychological data between subgroups.ResultsThere were no differences in any neuropsychological task between right-sided and left-sided onset subgroups, irrespective of tremor dominant or rigid-bradykinetic phenotype. Age at onset was significantly higher in patients with any cognitive impairment as compared with patients without (66.7 ± 3.2 vs. 56.3 ± 6.8 years, p = 0.001).ConclusionSide of motor onset is not a major determinant for developing lateralized cognitive deficits in newly diagnosed untreated PD patients. 相似文献
88.
89.
Gregor K Wenning Felix Geser Florian Krismer Klaus Seppi Susanne Duerr Sylvia Boesch Martin Köllensperger Georg Goebel Karl P Pfeiffer Paolo Barone Maria Teresa Pellecchia Niall P Quinn Vasiliki Koukouni Clare J Fowler Anette Schrag Christopher J Mathias Nir Giladi Tanya Gurevich Werner Poewe 《Lancet neurology》2013,12(3):264-274
90.